Skip to Main Content

Paper Details

Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer.
Eur J Cancer
9
2015
Author NameAffiliation
Kathleen I PritchardSunnybrook Odette Cancer Centre, University of Toronto
Dianne M FinkelsteinMassachusetts General Hospital
  • 1 - 2

Datasets

Release 1.2